Beringea added another exciting company to its portfolio as it recently welcomed Doctify, the verified feedback for healthcare specialists platform. The $10m funding round was also backed by existing investors, which included Keen Venture Partners, Amadeus Capital Partners and Guinness Ventures.
Doctify’s platform gathers patient feedback and presents it in a format which is transferable for clinicians to evaluate the quality of care. Each review goes through a rigorous screening process which in the healthcare industry is of great importance. There are already 50 million patients using the platform from Australia, UAE, Austria, and Germany, to the UK, and it is estimated that by 2025 Doctify’s reach will double in size.
Beringea is a transatlantic venture capital firm which invests in scaling companies. Focusing on Series A and Series B rounds, Beringea adds value through strategic connections, transatlantic growth, and the Beringea Scale-Up Academy. Carrie Babcock, Investment Manager at Beringea, commented on the transaction, saying that ‘Doctify is solving the healthcare journey through patient reviews but also by publishing professional endorsements between doctors’.
#investment #healthcare #medtech